3030-53-3 Usage
General Description
Clofenoxyde, also known as Flutamide, is a nonsteroidal antiandrogen drug that is primarily used to treat prostate cancer. It works by blocking the action of androgens, which are male hormones that can promote the growth of prostate cancer cells. By inhibiting the activity of androgens, Clofenoxyde can slow down the progression of the disease and reduce the size of tumors. It is often used in combination with other medications, such as LHRH agonists, to achieve the best results in the treatment of prostate cancer. While Clofenoxyde has been shown to be effective in managing the symptoms of the disease, it can also cause side effects such as liver toxicity, gynecomastia, and gastrointestinal disturbances, so it should be used with caution and under the supervision of a healthcare professional.
Check Digit Verification of cas no
The CAS Registry Mumber 3030-53-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,0,3 and 0 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3030-53:
(6*3)+(5*0)+(4*3)+(3*0)+(2*5)+(1*3)=43
43 % 10 = 3
So 3030-53-3 is a valid CAS Registry Number.
InChI:InChI=1/C16H12Cl2O3/c17-9-15(19)11-1-5-13(6-2-11)21-14-7-3-12(4-8-14)16(20)10-18/h1-8H,9-10H2
3030-53-3Relevant articles and documents
The impact of graphene nano-plates on the behavior of novel conducting polyazomethine nanocomposites
Hussein, Mahmoud A.,El-Shishtawy, Reda?M.,Obaid, Abdullah Y.
, p. 9998 - 10008 (2017)
The aim of the current work was to synthesize a new series of polyazomethine/graphene nano-plate nanocomposites in the form of PAMs/GNPa-e. Different compositions were fabricated according to the percentage of GNP loading. The composites were f
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 51-52, (2012/04/10)
This disclosure concerns novel compounds of Formula (I) as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds
DIARYL ETHERS
-
Page/Page column 25, (2010/11/05)
Compounds of the formula (I): including any possible stereoisomers thereof, or a pharmaceutically acceptable salt and/or solvate thereof, as well as pharmaceutical formulations and the use of compounds of formula I as HCV inhibitors.